BRIEF-Endo Pharmaceuticals presents new mid-stage data evaluating safety and effectiv
 

BRIEF-Endo Pharmaceuticals presents new mid-stage data evaluating safety and effectiveness of Xiaflex
* Endo Pharmaceuticals presents new phase 2 data evaluatingthe safety and effectiveness of Xiaflex(collagenase clostridiumhistolyticum) for dupuytren's disease **duleshttp://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...EE:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...EE:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/BQ1-7oyIUpo